Microcin C7 (MccC7) 1 is a small peptide antibiotic produced by Escherichia coli during the stationary phase of growth (1). The spectrum of activity of this microcin includes several members of the Enterobacteriaceae family (2). MccC7 exerts its bacteriostatic action by blocking protein synthesis. Like for other microcins, the bacterial strains that produce MccC7 are immune (resistant) to this microcin (3). The heptapeptide of MccC7 is synthesized in ribosomes (4) and undergoes posttranslational modifications to yield the mature molecule.The genetic determinants for MccC7 synthesis, export, and immunity have been cloned from the 43 kilobases E. coli pMccC7 plasmid into multicopy plasmids that overproduce MccC7 and express MccC7 immunity (5). These determinants lie on a 6.2-kilobase region of pMccC7, which has been entirely sequenced.2 Different complementary approaches, such as physical and phenotypical characterization of insertion mutations and complementation studies, have shown that this region contains six genes (mccABCDEF) (5).2 Genes A, B, C, D, and E are involved in the production of mature extracellular microcin. Genes C, E, and F code for self-immunity bestowing products. Genes mccA-D are directly involved in the synthesis and export of MccC7 and constitute an operon transcribed from a promoter (mccp), located upstream of mccA (4, 6). Expression of these genes is regulated by the cAMP-cAMP regulatory protein complex and by the stationary phase factor RpoS (also called AppR) (6, 7). 3 mccA codes for the unmodified peptide of MccC7, MRTGNAN (MccA) (4). The predicted gene polypeptide product of mccB (350 residues) is strikingly homologous to a 81-residue fragment of the ubiquitin-activating enzyme from different eucaryotic species (UBA1) (8), ThiF (9) and ChlN (10) from E. coli which participate, respectively, in the biosynthesis of thiamine pyrophosphate and of molibdopterin, and HesA, an enzyme required by Anabaena for nitrogen fixation (11). The predicted mccC product (404 residues) contains 11 potential transmembrane domains and displays significant similarity with stretches of transport proteins, 2 suggesting that MccC is responsible for MccC7 export and explaining why it also confers resistance to exogenous MccC7. The carboxyl end of the expected MccE 521-residue long polypeptide is highly similar to RimL, an enzyme that acetylates the ribosomal protein L12 from E. coli (12). Principally on the basis of this homology with an acetylating protein, and because target alteration is a common mechanism of antibiotic resistance (13), it has been proposed that MccE might confer MccC7 immunity to producing cells by acetylating the target of microcin C7.2 No similarity was found for the predicted MccD (267 residues) and MccF (334 residues) polypeptides.The knowledge of the chemical structure of MccC7 is neces-* This investigation was supported by funds from the Institut Pasteur, the Centre National de la Recherche Scientifique (URA 1129 and URA 489), and the European Union (Grant CI1*-CT92-0011 to F. M.). The...